Pfenex Inc. Contracts & Agreements
96 Contracts & Agreements
- Business Finance (21 contracts)
- Business Operations (6)
- Human Resources (20)
- Intellectual Property (13)
- Mergers & Acquisitions (2)
- Real Estate (4)
- Uncategorized (30)
- Agreement and Plan of Merger, dated as of August 10, 2020, by and among Pfenex, Inc., Ligand Pharmaceuticals Incorporated and Acquisition Sub (Filed With SEC on August 11, 2020)
- Deed of Assignment and Amendment, dated April 20, 2020, between the Registrant and NT Pharma, NT International, and Kangchen (Filed With SEC on August 6, 2020)
- Amendment No. 3 to the Development and License Agreement, dated May 26, 2020, between the Registrant and Alvogen Malta (Out-Licensing) Ltd (Filed With SEC on August 6, 2020)
- Amendment No. 2 to the Development and License Agreement, dated June 24, 2020, between the Registrant and Alvogen Malta Operations Ltd (Filed With SEC on August 6, 2020)
- Amendment No. 2 to the Development and License Agreement dated March 9, 2020, between the Registrant and Alvogen (Filed With SEC on May 7, 2020)
- Alvogen Malta (Out-Licensing) Ltd. Letter, Alvogen ROW Sublicense (Filed With SEC on May 7, 2020)
- Equity Sales Agreement, dated as of May 7, 2020, among Pfenex Inc., William Blair & Company, L.L.C., and H.C. Wainwright & Co., LLC (Filed With SEC on May 7, 2020)
- Description of Common Stock of the Company (Filed With SEC on March 11, 2020)
- Amendment No.1 to the Alvogen ROW Development and License Agreement (Filed With SEC on March 11, 2020)
- Transition Agreement and Limited Release, effective November 13, 2019, between the Registrant and Susan A. Knudson 23.1* Consent of KPMG LLP, Independent Registered Public... (Filed With SEC on March 11, 2020)
- Development and License Agreement dated February 25, 2019 by and between Pfenex Inc. and Alvogen Malta (Out-Licensing) Ltd (Filed With SEC on May 9, 2019)
- MENA Development and License Agreement dated February 25, 2019 by and between Pfenex Inc. and Alvogen Malta (Out-Licensing) Ltd (Filed With SEC on May 9, 2019)
- E.U. Development and License Agreement dated February 25, 2019 by and between Pfenex Inc. and Alvogen Malta (Out-licensing) Ltd (Filed With SEC on May 9, 2019)
- Amendment No. 1 to the Development and License Agreement dated February 25, 2019 between Pfenex Inc. and Alvogen Malta Operations Ltd (Filed With SEC on May 9, 2019)
- Executive Employment Agreement dated March 18, 2019 by and between Pfenex Inc. and Martin Brenner (Filed With SEC on May 9, 2019)
- Amended and Restated 2014 Equity Incentive Plan and forms of award thereunder (Filed With SEC on May 9, 2019)
- Transition Agreement and Release by and between the Company and Hubert C. Chen dated August 16, 2018 (Filed With SEC on November 7, 2018)
- Modification No. 7, effective September 14, 2018, to Cost Plus Fixed Fee Agreement, dated August 14, 2015, between the Registrant and the United States Department of Health and... (Filed With SEC on November 7, 2018)
- Executive Employment Agreement, effective October 1, 2018, between the Company and Shawn A. Scranton, PharmD (Filed With SEC on September 11, 2018)
- Development and License Agreement, dated April 18, 2018, between the Registrant and China NT Pharma Group Company Limited (Filed With SEC on August 8, 2018)
- Modification 6, effective May 15, 2018, between the Registrant and the United States Department of Health and Human Services (Filed With SEC on August 8, 2018)
- Development and License Agreement, dated June 11, 2018, between the Registrant and Alvogen Malta Operations Ltd (Filed With SEC on August 8, 2018)
- Underwriting Agreement, dated as of May 23, 2018, by and among Pfenex Inc. and Barclays Capital Inc. and William Blair & Company, L.L.C. as representatives of the underwriters (Filed With SEC on May 23, 2018)
- Amended License and Option Agreement, dated December 19, 2017, by and between the Registrant and Jazz Pharmaceuticals Ireland Limited (Filed With SEC on March 15, 2018)
- Sales Agreement, dated as of March 15, 2018, between Pfenex Inc. and William Blair & Company, L.L.C (Filed With SEC on March 15, 2018)
- Executive Employment Agreement, effective February 1, 2018, between the Company and Susan A. Knudson (Filed With SEC on January 4, 2018)
- Modification No. 5, effective August 2, 2017, to Cost Plus Fixed Fee Agreement, dated August 14, 2015, between the Registrant and the United States Department of Health and Human... (Filed With SEC on November 9, 2017)
- Mutual Separation Agreement and Mutual Release by and between the Company and Paul A. Wagner dated September 7, 2017 (Filed With SEC on September 7, 2017)
- Mutual Separation Agreement and Mutual Release by and between the Company and Steven Sandoval dated September 7, 2017 (Filed With SEC on September 7, 2017)
- TERMINATION AGREEMENT (Filed With SEC on August 9, 2017)
- PFENEX INC. EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on August 3, 2017)
- PFENEX INC. 2014EQUITY INCENTIVE PLAN (As Amended and Restated May 5, 2017) (Filed With SEC on May 8, 2017)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 15, 2017)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 15, 2017)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 15, 2017)
- SEPARATION AGREEMENT AND RELEASE (Filed With SEC on January 24, 2017)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on November 9, 2016)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on November 9, 2016)
- PFENEX INC. EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2016)
- PFENEX INC. 2016INDUCEMENT EQUITY INCENTIVE PLAN (Filed With SEC on November 9, 2016)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on August 8, 2016)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on May 9, 2016)
- THIRD AMENDMENT TO MULTI-TENANT INDUSTRIAL/COMMERCIAL LEASE (NET) (Roselle Technology Park) (Filed With SEC on May 9, 2016)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on May 9, 2016)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on May 9, 2016)
- SECOND AMENDMENT TO MULTI-TENANT INDUSTRIAL/COMMERCIAL LEASE (NET) (Roselle Technology Park) (Filed With SEC on March 10, 2016)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 10, 2016)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 10, 2016)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 10, 2016)
- 600,000 Shares PfenexInc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on December 16, 2015)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on November 13, 2015)
- FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (Filed With SEC on November 13, 2015)
- AMENDED AND RESTATED CREDITAGREEMENT (Filed With SEC on July 6, 2015)
- AMENDED AND RESTATED REVOLVINGLINE OF CREDIT NOTE (Filed With SEC on July 6, 2015)
- [ l ] Shares Pfenex Inc. CommonStock UNDERWRITING AGREEMENT (Filed With SEC on April 23, 2015)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on April 23, 2015)
- CREDIT AGREEMENT (Filed With SEC on April 15, 2015)
- REVOLVING LINE OF CREDIT NOTE (Filed With SEC on April 15, 2015)
- REVOLVING LINE OF CREDIT NOTE (Filed With SEC on April 15, 2015)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on April 15, 2015)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on April 15, 2015)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 16, 2015)
- THIRD AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on March 16, 2015)
- PFENEX INC. EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2015)
- PAGE OF PAGES 1 | 4 (Filed With SEC on March 16, 2015)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 16, 2015)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on November 14, 2014)
- FIRST AMENDMENT TO MULTI-TENANT INDUSTRIAL/COMMERCIAL LEASE (NET) (Roselle Technology Park) (Filed With SEC on September 25, 2014)
- PFENEX INC. 2014EQUITY INCENTIVE PLAN (Filed With SEC on July 17, 2014)
- [] Shares Pfenex Inc. CommonStock UNDERWRITING AGREEMENT (Filed With SEC on July 7, 2014)
- PFENEX INC. INVESTORS RIGHTS AGREEMENT (Filed With SEC on July 7, 2014)
- PFENEX INC. 2014EQUITY INCENTIVE PLAN (Filed With SEC on July 7, 2014)
- PFENEX INC. 2014EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on July 7, 2014)
- CREDIT AGREEMENT (Filed With SEC on July 7, 2014)
- SECURITY AGREEMENT: SPECIFICRIGHTS TO PAYMENT (Filed With SEC on July 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on June 25, 2014)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on June 25, 2014)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on June 25, 2014)
- PFENEX INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 23, 2014)
- PFENEX INC. EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 23, 2014)
- PFENEX INC. EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 23, 2014)
- PFENEX INC. EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 23, 2014)
- PFENEX INC. EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 23, 2014)
- PFENEX INC. EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 23, 2014)
- PFENEX INC. INCENTIVE COMPENSATION PLAN Adopted by the Board of Directors on June 17, 2014 and effective immediately prior to the Companys initial public offering (Filed With SEC on June 23, 2014)
- PFENEXINC. INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS (Filed With SEC on June 5, 2014)
- AMENDED ANDRESTATED SUBSCRIPTION AGREEMENT (Filed With SEC on June 5, 2014)
- PFENEX INC. 2009EQUITY INCENTIVE PLAN (Filed With SEC on June 5, 2014)
- PFENEX INC. INDEMNIFICATION AGREEMENT (Filed With SEC on June 5, 2014)
- BRS-TUSTIN SAFEGUARD ASSOCIATES II, LLC Multi Tenant Industrial/Commercial Lease (Net) Between BRS-TUS7TN SAFEGUARD ASSOCIATES II, LLC, a Delaware limited liability company... (Filed With SEC on June 5, 2014)
- JOINT DEVELOPMENT & LICENSE AGREEMENT (Filed With SEC on June 5, 2014)
- PFENEX INC. AND AGILABIOTECH PRIVATE LIMITED JOINT VENTURE AGREEMENT JOINT VENTURE AGREEMENT (Filed With SEC on June 5, 2014)
- TECHNOLOGYLICENSING AGREEMENT (Filed With SEC on June 5, 2014)
- GRANT-BACK AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on June 5, 2014)
- TECHNOLOGY ASSIGNMENT AGREEMENT (Filed With SEC on June 5, 2014)
- CONTRIBUTION,ASSIGNMENT AND ASSUMPTION AGREEMENT by and among THE DOW CHEMICAL COMPANY, DOW GLOBAL TECHNOLOGIES INC. and PFENEX INC. NOVEMBER 30, 2009 (Filed With SEC on June 5, 2014)